Do long-acting ß2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
Number of pages
SourceEuropean Respiratory Journal, 15, (2000), pp. 631-634
Article / Letter to editor
Display more detailsDisplay less details
European Respiratory Journal
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.